Panakes Partners is the famous VC, which was founded in 2015. The fund was located in Europe if to be more exact in Italy. The leading representative office of defined VC is situated in the Milano.
The fund was created by Alessio Beverina, Diana Saraceni, Fabrizio Landi.
The high activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. The real fund results show that this VC is 57 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 deals per year.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Panakes Partners, startups are often financed by Fountain Healthcare Partners, Foundation for Technological Innovation (FIT), EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Fountain Healthcare Partners, btov Partners, Supernova Invest. In the next rounds fund is usually obtained by iStarter, European Investment Bank (EIB).
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Echolight.it, Seventeen, Alesi Surgical. We can highlight the next thriving fund investment areas, such as Medical, Robotics. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Italy.
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Nouscom | $8M | 21 Mar 2024 | Basel, Basel-City, Switzerland | ||
MMI | $110M | 21 Feb 2024 | Italy, Tuscany, Italy | ||
Enterprise Therapeutics | $35M | 29 Jan 2024 | United Kingdom, England, United Kingdom | ||
DISCO Pharmaceuticals | $23M | 16 Jan 2024 | Cologne, Nordrhein-Westfalen, Germany | ||
Nouscom | $79M | 14 Nov 2023 | Basel, Basel-City, Switzerland | ||
Allotex | $30M | 09 Jul 2023 | Boston, Massachusetts, United States | ||
EBAMed | $16M | 27 Jun 2023 | Geneva, Geneva, Switzerland | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
Neuromod Devices | $17M | 13 Apr 2023 | Dublin, County Dublin, Ireland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Nouscom | $8M | 21 Mar 2024 | Basel, Basel-City, Switzerland | ||
MMI | $110M | 21 Feb 2024 | Italy, Tuscany, Italy | ||
Enterprise Therapeutics | $35M | 29 Jan 2024 | United Kingdom, England, United Kingdom | ||
DISCO Pharmaceuticals | $23M | 16 Jan 2024 | Cologne, Nordrhein-Westfalen, Germany | ||
Nouscom | $79M | 14 Nov 2023 | Basel, Basel-City, Switzerland | ||
Allotex | $30M | 09 Jul 2023 | Boston, Massachusetts, United States | ||
EBAMed | $16M | 27 Jun 2023 | Geneva, Geneva, Switzerland | ||
Complement Therapeutics | $84M | 17 Apr 2023 | London, England, United Kingdom | ||
Neuromod Devices | $17M | 13 Apr 2023 | Dublin, County Dublin, Ireland |